DOC HEALTHPEAK PROPERTIES, INC. Insider Trading

Director Thomas John T bought 1,450 shares of DOC at $17.06 on 2025-08-06 ($24,729.75); prior buy at same ticker was underwater.

Thomas John T, a director, purchased 1,450 shares at $17.06, increasing his holdings from 808.6K to 810.0K shares. His prior buy at this ticker on 2025-04-28 delivered a 90-day return of -1.4%, placing this transaction in the context of a track record where 0 of 1 prior buys were well-timed at the 90-day mark. The stock has declined 27.1% from its 52-week high of $23.12 and is trading below the transaction price at the current $16.85. The purchase size represents only 0.2% of his existing holdings, suggesting a marginal position adjustment rather than a material conviction-driven accumulation in a healthcare REIT that carries a P/E of 70.21.

Brinker (CEO) bought 1,490 shares of DOC at $16.83 on 2025-08-04; stock now $16.90, down 26.9% from 52-week high.

CEO Scott M Brinker purchased 1,490 shares at $16.83, a modest $25,076.70 addition to his 211.9K-share position. The purchase occurred after three recent buys within the prior week (2025-07-28, 2025-07-31), suggesting repeated accumulation while the stock trades near its 52-week low of $16.77. However, Brinker's historical performance as a buyer provides limited confidence: his cross-ticker track record shows zero wins in 90-day holding periods, and his single measurable prior DOC purchase (2025-04-28) delivered a 90-day return of -0.4%. The stock has declined 7.2% over the past 30 days, trading 26.9% below its 52-week high, presenting a context of sustained weakness rather than a clear inflection point.

HealthPeak Properties CEO Scott M Brinker bought 2,930 shares at $17.06 on 2025-07-31, expanding holdings to 210,416 shares.

CEO Scott M Brinker purchased 2,930 shares at $17.06, a transaction worth $49,985.80. The purchase occurred near the 52-week low of $16.82 and represents only a 1.4% increase to his 210,416-share holdings. Notably, Brinker has executed three buys at HealthPeak within recent months (2025-04-28, 2025-05-09, and 2025-07-28), yet his same-ticker track record shows prior buys delivered -1.5% and -0.8% returns within 30 days, with his 90-day timing pattern at zero. Across all holdings and tickers, his historical buys averaged -1.1% 30-day return and -0.4% 90-day return with a 0.00% win rate, suggesting consistent poor timing despite repeated acquisitions. The stock trades at a P/E of 70.58 with -26.7% decline from its 52-week high, yet the insider's purchasing pattern shows no historical ability to identify attractive entry points.

CEO Brinker buys 2,873 shares of HEALTHPEAK (DOC) at $17.40; stock down -24.9% from 52-week high.

CEO Scott M. Brinker purchased 2,873 shares at $17.40 on 2025-07-28, increasing his holdings from 204.6K to 207.5K shares. The stock currently trades at $17.37, near the lower end of its 52-week range ($16.82–$23.12) and down -24.9% from its 52-week high, suggesting a depressed entry point. However, Brinker's prior trades at DOC (two previous purchases on 2025-04-28 and 2025-05-09) show a pattern of negative returns: the April buy posted -0.4% over 90 days, while the May buy remains unresolved. Across his open-market history spanning multiple tickers, his 90-day win rate stands at 0.00%, indicating his purchase timing has not consistently preceded stock appreciation. The $50.0K purchase represents a modest 1.4% increase to his existing position in a company with a P/E of 72.38 and strong revenue growth of +23.8% annually, but without clear evidence of improved timing discipline.

Director Tommy G Thompson buys 5,777 shares of Healthpeak Properties at $17.27; stock down 13.7% in 90 days

Director Thompson purchased 5,777 shares at $17.27 on 2025-05-28, increasing his holdings from 138,513 to 144,290 shares—a modest 4.2% addition to existing position. The purchase occurred while the stock trades at $17.41 (current price), down 13.7% over the past 90 days and 24.7% below its 52-week high of $23.12. Thompson's prior open-market trade at this ticker occurred just 19 days earlier (2025-05-09 buy), and outcomes remain unmeasurable; his cross-ticker track record shows 2 prior buys with an average 30-day return of +3.8%, but no pattern of well-timed purchases at the 90-day mark across his broader history. The company reports strong fundamentals—$702.9M quarterly revenue (+23.8% annual growth) and a P/E of 43.52—but the stock's recent weakness and this director's recent repurchase activity following an earlier buy warrant observation rather than confident interpretation.

CEO Brinker Scott M buys 2,750 shares of Healthpeak Properties at $17.39; joins 6 other insiders in cluster buy pattern.

Scott M. Brinker, President and CEO of Healthpeak Properties, purchased 2,750 shares at $17.39 on 2025-05-09, expanding his holdings to 204,613 shares. This purchase occurs within a cluster buy pattern, with 6 other insiders also buying within the past 14 days, suggesting coordinated or synchronized conviction among the leadership team. The stock currently trades at $17.55, only 0.9% above the transaction price, but is -24.1% from its 52-week high of $23.12 and down -10.5% over the past 90 days, indicating recent weakness. The company's fundamentals appear sound—annual revenue growth of +23.8%, net income of $42,828,000.00 on quarterly revenue of $702,889,000.00—though the elevated P/E of 43.88 reflects high market expectations relative to earnings. The synchronized buying by multiple executives during a period of stock underperformance relative to its 52-week range warrants monitoring to assess whether leadership's capital deployment signals underlying confidence in valuation or near-term recovery prospects.

Director Thompson Tommy G buys 5,700 shares of HEALTHPEAK PROPERTIES at $17.36; 6 other insiders also bought in past 14 days (cluster pattern).

Director Tommy G Thompson purchased 5,700 shares at $17.36 on 2025-05-09, increasing his holdings from 132.8K shares to 138.5K shares. This purchase is noteworthy for its placement within a cluster: 6 other insiders also bought within the past 14 days, suggesting coordinated or independent but synchronized appetite at the current price level. The stock currently trades at $17.55, having declined 3.4% over the past 30 days and 10.5% over 90 days, positioning this buy approximately 24.1% below the 52-week high of $23.12. While Thompson's cross-ticker track record shows only 1 prior buy against 3 prior sells (averaging 11.8% 90-day returns), the multi-insider cluster buy pattern may signal perceived value at recent price levels, though the company's elevated P/E of 43.88 against $12.2B market cap warrants investor attention to valuation context.

Director Ava Lias-Booker bought 5,000 shares of DOC at $17.83; 5 other insiders also bought within 14 days

Director Ava Lias-Booker purchased 5,000 shares at $17.83 on 2025-04-29, increasing her holdings to 35,561 shares. The transaction occurs within a cluster pattern: 5 other insiders also bought within the past 14 days, suggesting broad insider interest at current levels. The stock has declined -23.2% from its 52-week high of $23.12 and is down -12.0% over the past 30 days, trading at $17.76 (near the transaction price). With annual revenue growth of +23.8% and a market cap of $12.3B, the company is expanding revenue, though the elevated P/E of 44.40 reflects market expectations. The convergence of multiple insider purchases during a price decline warrants investor attention to the motivations underlying this synchronized activity.

Director Katherine M. Sandstrom buys 11,288 shares of DOC at $17.65; 4 other insiders bought within 14 days.

Sandstrom purchased 11,288 shares at $17.65 on 2025-04-28, increasing her holdings by 25.1% to 56,268 shares total. The transaction occurs in the context of a multi-insider cluster, with 4 other insiders also purchasing within the past 14 days. The current price of $17.75 is 23.2% below the 52-week high of $23.12, and the stock has declined 12.1% over 30 days and 14.1% over 90 days. HealthPeak Properties reports a P/E of 44.38 and recent quarterly revenue of $702,889,000.00 with annual growth of 23.8%. The synchronized buying pattern across multiple insiders, combined with the stock trading near its 52-week low, suggests company leadership is accumulating shares during a period of depressed equity pricing.

Director Sara Grootwassink buys 6,000 DOC shares at $17.66; 4 other insiders bought in past 14 days

Lewis Sara Grootwassink, a Director, purchased 6,000 shares of HEALTHPEAK PROPERTIES, INC. at $17.66 on 2025-04-28, tripling her position from 3,000 to 9,000 shares for a total value of $105,938.40. This purchase occurs within a broader cluster pattern: 4 other insiders also bought within the past 14 days, suggesting coordinated or convergent conviction among the leadership group. The transaction is priced near the 52-week low (current price $17.75 is -23.2% from the 52-week high of $23.12), and the insider's prior buy at this ticker on 2024-03-04 subsequently returned +19.1% over 90 days, indicating a history of well-timed entry points. The company's fundamentals show revenue of $702,889,000.00 and annual revenue growth of +23.8%, though the elevated P/E of 44.38 reflects market expectations not yet earned out in recent net income of $42,828,000.00.